Montanaro Asset Management’s MaxCyte MXCT Stock Holding History

Montanaro Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-29,000	Closed	-$130K	–	46
2023 Q4	$130K	Hold	29,000	–	–	0.02%	42
2023 Q3	$90.2K	Hold	29,000	–	–	0.02%	45
2023 Q2	$129K	Hold	29,000	–	–	0.02%	45
2023 Q1	$139K	Sell	29,000 -900,000	-97%	-$4.43M	0.02%	44
2022 Q4	$4.92M	Hold	929,000	–	–	0.8%	32
2022 Q3	$6.01M	Hold	929,000	–	–	0.92%	32
2022 Q2	$4.3M	Hold	929,000	–	–	0.65%	34
2022 Q1	$6.56M	Sell	929,000 -450,000	-33%	-$3.07M	0.81%	30
2021 Q4	$14.1M	Sell	1,379,000 -1,170,000	-46%	-$12.6M	1.42%	23
2021 Q3	$31M	Buy	+2,549,000	New	+$38.4M	3.74%	11

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Montanaro Asset Management's MXCT Position: Q1 2024 in Review

Montanaro Asset Management sold out of MaxCyte (MXCT) in Q1 2024, closing a stake of 29,000 shares — an estimated $130K sold.

Montanaro Asset Management first reported a position in MXCT in Q3 2021 and held it in 10 quarters. The position peaked at $31M in Q3 2021. 123 funds tracked by Wall St. Rank hold MXCT as of Q1 2024.

Montanaro Asset Management reported no remaining MaxCyte position as of Q1 2024 after selling out during the quarter.
Montanaro Asset Management sold 29,000 MaxCyte shares in Q1 2024, an estimated $130K.
Montanaro Asset Management first reported a position in MaxCyte in Q3 2021 and held it in 10 quarters.
Montanaro Asset Management's MaxCyte position peaked at $31M in Q3 2021.
123 funds tracked by Wall St. Rank held MaxCyte as of Q1 2024.

Based on Montanaro Asset Management's 13F filing for Q1 2024, filed 14 May 2024.